Galecto Inc
NASDAQ:GLTO
Galecto Inc
Accrued Liabilities
Galecto Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Accrued Liabilities
$2.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Accrued Liabilities
kr51.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Accrued Liabilities
kr308.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
Bioporto A/S
CSE:BIOPOR
|
Accrued Liabilities
kr16.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Galecto Inc's Accrued Liabilities?
Accrued Liabilities
2.9m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Accrued Liabilities amounts to 2.9m USD.
What is Galecto Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
71%
Over the last year, the Accrued Liabilities growth was 164%. The average annual Accrued Liabilities growth rates for Galecto Inc have been 28% over the past three years , 71% over the past five years .